Firms

Citta Capital

Palo Alto, California, United States

Citta Capital is a Palo Alto venture-capital firm founded in 2020, focused on early-stage and early-growth technology companies. It invests in artificial intelligence and machine learning, cloud and data infrastructure, enterprise software, healthcare technology, robotics and other emerging technologies. Founding and Managing Partner Jim Mao is the Managing Member of legal adviser Citta Capital Management, LLC, CRD322343, which files as an exempt reporting adviser. Its current public communications identify Jim Mao, Fred Sun and Shane Wilson; Shane is described as Venture Partner in firm posts and Managing Partner in his 2026 interview. The firm helps entrepreneurs develop products, enter markets and scale globally, drawing on startup and operating experience. Its neuroscience and life-science portfolio includes voice-based mental-health technology Kintsugi, stroke-monitoring developer Zeit Medical, bioelectronic-medicine company SetPoint Medical, Ordaos Bio and Synaptec Health. Its AI and deep-tech portfolio also includes Kamiwaza, Avoca, Visto and Finwave. Three exact legal private vehicles are disclosed in its March2026 adviser filing: Citta Capital, LP; Citta Capital Emerging Tech LLC; and Citta Capital Growth Opportunity LLC. Verified completed fund commitments and closing dates are undisclosed; reported asset values do not establish fundraising closes. Citta’s 2020 venture manager is distinct from the older Asian-equities firm of the same name and the Singapore entity with an unverified relationship.

Founded: 2020
Type: Venture capital